• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Decrim Update: Psychedelic Bills Move Forward in Several States

Microdose NewsDesk by Microdose NewsDesk
March 22, 2023
in Law & Politics
Reading Time: 3 mins read
A A
Psychedelic Reform and Decrim Update

2023 has started off as a good year for psychedelic decriminalization.

The year started with Oregon implementing its legalized psilocybin therapy programs, and a few days later, the state of New York announced a bill to legalize some psychedelics for adults 21 and older. We then had bills introduced by Hawaii, Virginia, and Missouri. 

Continuing the trend, we have several other states voting on psychedelic reform bills.

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

California Senate Committee Passes Psychedelics Legalization Bill 

Senate Bill 58 was introduced by Senator Scott Wiener, California’s legislative decrim champion. The bill would legalize personal possession of psilocybin, DMT, mescaline, and ibogaine — and it has passed through the California Public Safety Committee by a 3 to 1 vote. 

The law would allow the “…possession, preparation, obtaining, transfer, as specified, or transportation of the above-mentioned substances for personal or facilitated use”. 

The bill also permits “group counseling and community-based healing” and legalizes “any spores or mycelium capable of producing mushrooms or other material which contain psilocybin or psilocyn.”

 The bill still faces many steps. It now heads to the Senate Appropriations Committee for approval, and then onto a vote by the full Senate.

 

 

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Minnesota Reviewing Bill To Create Psychedelics Legalization Task Force 

The Minnesota state House committee on Thursday took up a

Buy Lasix Online Now

bill to establish a task force to study and advise on the potential legalization of psychedelics like psilocybin, MDMA and ibogaine.

The Psychedelic Medicine Task Force would: 

“advise the legislature on the legal, medical, and policy issues associated with the legalization of psychedelic medicine in the state.”

and…

“survey existing studies in the scientific literature on the therapeutic efficacy of psychedelic medicine in the treatment of mental health conditions, including depression, anxiety, post-traumatic stress disorder, and bipolar disorder, and any other mental health conditions and medical conditions for which a psychedelic medicine may provide an effective treatment option…” 

 

 

Oklahoma bill passes, championing increased study of psychedelic mushrooms

A bill calling for the study of psilocybin has passed the Oklahoma House. 

The bill would allow universities and research facilities to conduct research into psilocybin and psilocyn. It passed the House in a 66-32 vote and now moves on to the Senate for review.

Keep in mind that Oklahoma is a very conservative state, so this move forward shows the continued support for psychedelics in traditionally Republican strongholds. 

Because of this conservative demographic, this version of the bill had been amended to remove any direct decriminalization language. However, it did retain protections for people facing prosecution over psilocybin possession, if they could show they’re dealing with certain medical conditions like PTSD. 

 

 

For more decrim and legalization news, check out 2023 Starts With Psychedelic Decrim Measures In Several States and Australia Legalizes Psychedelics: Are the US and Canada Next?

Tags: Decriminalization
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Field Trip Announces New Ketamine Therapy Program: Freedom by Field Trip™

Field Trip Health & Wellness Files for Credit Protection; CEO Resigns

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.